Table 2 Distribution of cases according to Age, USG score, menopausal status, serum CA 125 levels and RMI
Parameter | Benign | Malignant | p-value |
|---|---|---|---|
Age | |||
≤ 20 | 5 (3.97%) | 2 (1.59%) | |
20–39 | 26 (20.63%) | 11 (8.7%) | |
40–59 | 21 (16.7%) | 48 (38.1%) | |
≥ 60 | 5 (3.97%) | 08 (6.35%) | |
Menstrual status | |||
Premenopausal | 48 (62.34%) | 29 (37.66%) | 0.000 |
Postmenopausal | 9 (18.4%) | 40 (81.6%) | 0.000 |
USG characteristics | |||
Bilateral | 16 (45.72%) | 19 (54.28%) | 0.947 |
Multilocular | 29 (46.03%) | 34 (53.97%) | 0.859 |
Presence of solid areas | 20 (24.69%) | 61 (75.30%) | 0.000 |
Presence of ascites | 9 (18.75%) | 39 (81.25%) | 0.000 |
Presence of metastasis | 1 (5.5%) | 17 (94.4%) | 0.000 |
USG SCORE | |||
1 | 35 (61.4%) | 22 (38.6%) | 0.001 |
3 | 22 (31.88%) | 47 (61.12%) | |
SerumCA-125(U/ml) (Mean ± Sd) | 69.89 ± 44.10 | 502.09 ± 1525.09 | 0.001 |
RMI (Mean ± Sd) | 109.06 ± 47.49 | 3534.57 ± 13,653.83 | 0.013 |
RMI ≥ 236 | 1 (1.75%) | 56 (98.24%) | 0.000 |
RMI <236 | 56 (74.66%) | 19 (25.34) | |